Table of Contents Asia-Pacific Bioengineered Protein Drugs Market Report 2012-2023 1 Bioengineered Protein Drugs Overview 1.1 Product Overview and Scope of Bioengineered Protein Drugs 1.2 Classification of Bioengineered Protein Drugs by Product Category 1.2.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 Therapeutic Proteins 1.2.4 Monoclonal Antibodies 1.2.5 Vaccines 1.3 Asia-Pacific Bioengineered Protein Drugs Market by Application/End Users 1.3.1 Asia-Pacific Bioengineered Protein Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Diabetes and Hormonal Disorders 1.3.3 Genetic and Fertility Disorders 1.3.4 Cancers 1.3.5 Organ Transplants 1.3.6 Others 1.4 Asia-Pacific Bioengineered Protein Drugs Market by Region 1.4.1 Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 China Status and Prospect (2012-2023) 1.4.3 Japan Status and Prospect (2012-2023) 1.4.4 South Korea Status and Prospect (2012-2023) 1.4.5 Taiwan Status and Prospect (2012-2023) 1.4.6 India Status and Prospect (2012-2023) 1.4.7 Southeast Asia Status and Prospect (2012-2023) 1.4.8 Australia Status and Prospect (2012-2023) 1.5 Asia-Pacific Sales and Revenue ofSales and Revenue of Bioengineered Protein Drugs (2012-2023) 1.5.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Bioengineered Protein Drugs 2.2 Raw Material Analysis of Bioengineered Protein Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of K Units 2.4 Other Costs Analysis of Bioengineered Protein Drugs 2.5 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs 2.6 Manufacturing Process Analysis of Bioengineered Protein Drugs 2.7 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 Asia-Pacific Bioengineered Protein Drugs Players/Suppliers Profiles and Sales Data 3.1 Abbott Laboratories 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Abbott Laboratories Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Abbott Laboratories Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.2 F. Hoffmann-La Roche Ltd 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 F. Hoffmann-La Roche Ltd Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.3 Amgen, Inc. 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Amgen, Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Amgen, Inc. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Amgen, Inc. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.4 Bayer AG 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Bayer AG Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Bayer AG Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Bayer AG Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.5 Merck & Co., Inc. 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Merck & Co., Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Merck & Co., Inc. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Merck & Co., Inc. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.6 Dr. Reddy's Laboratories Ltd. 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Dr. Reddy's Laboratories Ltd. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.7 Biocon Ltd. 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Biocon Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Biocon Ltd. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Biocon Ltd. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.8 Eli Lilly and Company 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Eli Lilly and Company Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Eli Lilly and Company Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Eli Lilly and Company Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.9 Sanofi 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Sanofi Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Sanofi Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.10 GlaxoSmithKline plc 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 GlaxoSmithKline plc Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 GlaxoSmithKline plc Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.11 Johnson & Johnson 3.12 JanssenNovartis AG 3.13 Panacea Biotec 3.14 ProBioGen AG 4 Asia-Pacific Bioengineered Protein Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 Asia-Pacific Bioengineered Protein Drugs Market Competition by Players/Manufacturers 4.1.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Asia-Pacific Bioengineered Protein Drugs Sales and Revenue by Type 4.2.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Asia-Pacific Bioengineered Protein Drugs Sales and Revenue by Application 4.3.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) by Application 5 China Bioengineered Protein Drugs (Sales, Revenue and Price) 5.1 China Bioengineered Protein Drugs Sales and Value (2012-2017) 5.1.1 China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 China Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 5.1.3 China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 China Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 5.3 China Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 6 Japan Bioengineered Protein Drugs (Sales, Revenue and Price) 6.1 Japan Bioengineered Protein Drugs Sales and Value (2012-2017) 6.1.1 Japan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Japan Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 6.1.3 Japan Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 Japan Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 6.3 Japan Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 7 South Korea Bioengineered Protein Drugs (Sales, Revenue and Price) 7.1 South Korea Bioengineered Protein Drugs Sales and Value (2012-2017) 7.1.1 South Korea Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Korea Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 7.1.3 South Korea Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Korea Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 7.3 South Korea Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 8 Taiwan Bioengineered Protein Drugs (Sales, Revenue and Price) 8.1 Taiwan Bioengineered Protein Drugs Sales and Value (2012-2017) 8.1.1 Taiwan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Taiwan Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Taiwan Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 Taiwan Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 8.3 Taiwan Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 9 India Bioengineered Protein Drugs (Sales, Revenue and Price) 9.1 India Bioengineered Protein Drugs Sales and Value (2012-2017) 9.1.1 India Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 9.1.2 India Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 9.1.3 India Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 9.2 India Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 9.3 India Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 10 Southeast Asia Bioengineered Protein Drugs (Sales, Revenue and Price) 10.1 Southeast Asia Bioengineered Protein Drugs Sales and Value (2012-2017) 10.1.1 Southeast Asia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Southeast Asia Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 10.1.3 Southeast Asia Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 10.2 Southeast Asia Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 10.3 Southeast Asia Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 11 Australia Bioengineered Protein Drugs (Sales, Revenue and Price) 11.1 Australia Bioengineered Protein Drugs Sales and Value (2012-2017) 11.1.1 Australia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Australia Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 11.1.3 Australia Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 11.2 Australia Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 11.3 Australia Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Asia-Pacific Bioengineered Protein Drugs Market Forecast (2018-2023) 13.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Asia-Pacific Bioengineered Protein Drugs Price and Trend Forecast (2018-2023) 13.2 Asia-Pacific Bioengineered Protein Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 China Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 Japan Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 South Korea Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Taiwan Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 South Korea Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Southeast Asia Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Australia Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Asia-Pacific Bioengineered Protein Drugs Sales Forecast by Type (2018-2023) 13.3.2 Asia-Pacific Bioengineered Protein Drugs Revenue Forecast by Type (2018-2023) 13.3.3 Asia-Pacific Bioengineered Protein Drugs Price Forecast by Type (2018-2023) 13.4 Asia-Pacific Bioengineered Protein Drugs Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Asia-Pacific Market Size (Million USD) Comparison 2012-2023 Table Asia-Pacific Market Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Bioengineered Protein Drugs Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Market Share by Types in 2017 Figure Therapeutic Proteins Picture Figure Monoclonal Antibodies Picture Figure Vaccines Picture Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure Asia-Pacific Sales Market Share of Bioengineered Protein Drugs by Applications in 2017 Figure Diabetes and Hormonal Disorders Picture Figure Genetic and Fertility Disorders Picture Figure Cancers Picture Table Asia-Pacific Market Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure South Korea Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Taiwan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Australia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2023) Figure Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Bioengineered Protein Drugs Table Industry News List of Bioengineered Protein Drugs Figure Industry Chain Structure of Bioengineered Protein Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs in 2017 Figure Manufacturing Process Analysis of Bioengineered Protein Drugs Table Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2017 Table Major Buyers of Bioengineered Protein Drugs Table Abbott Laboratories Basic Information List Table Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Abbott Laboratories Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Abbott Laboratories Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Abbott Laboratories Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table F. Hoffmann-La Roche Ltd Basic Information List Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Amgen, Inc. Basic Information List Table Amgen, Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Amgen, Inc. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Amgen, Inc. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Amgen, Inc. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Bayer AG Basic Information List Table Bayer AG Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Bayer AG Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Bayer AG Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Bayer AG Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Merck & Co., Inc. Basic Information List Table Merck & Co., Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Dr. Reddy's Laboratories Ltd. Basic Information List Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Biocon Ltd. Basic Information List Table Biocon Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Biocon Ltd. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Biocon Ltd. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Biocon Ltd. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Eli Lilly and Company Basic Information List Table Eli Lilly and Company Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Eli Lilly and Company Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Eli Lilly and Company Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Eli Lilly and Company Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Sanofi Basic Information List Table Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Sanofi Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Sanofi Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sanofi Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Sanofi Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Sanofi Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Company GlaxoSmithKline plc Basic Information List Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company GlaxoSmithKline plc Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Company GlaxoSmithKline plc Bioengineered Protein Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Company GlaxoSmithKline plc Bioengineered Protein Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Asia-Pacific Bioengineered Protein Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 Asia-Pacific Bioengineered Protein Drugs Sales Share by Players/Manufacturers Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Asia-Pacific Bioengineered Protein Drugs Revenue Market Share (%) Players Figure 2017 Asia-Pacific Bioengineered Protein Drugs Revenue Market Share (%) Players Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Bioengineered Protein Drugs by Type (2012-2017) Figure Asia-Pacific Bioengineered Protein Drugs Sales Growth Rate (%) by Type (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Bioengineered Protein Drugs by Type (2012-2017) Figure Asia-Pacific Bioengineered Protein Drugs Revenue Growth Rate by Type (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Bioengineered Protein Drugs by Regions (2012-2017) Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Regions in 2017 Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Bioengineered Protein Drugs by Regions (2012-2017) Figure Asia-Pacific Bioengineered Protein Drugs Revenue Market Share by Regions in 2017 Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Market Share by Application (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Sales Share (%) by Application (2012-2017) Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Application (2012-2017) Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Application (2012-2017) Figure China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure China Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table China Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table China Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure China Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table China Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure China Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure Japan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Japan Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Japan Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Japan Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Japan Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Japan Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Japan Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Japan Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure South Korea Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure South Korea Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Korea Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table South Korea Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table South Korea Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure South Korea Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table South Korea Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table South Korea Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure South Korea Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure Taiwan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Taiwan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Taiwan Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Taiwan Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Taiwan Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Taiwan Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Taiwan Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Taiwan Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Taiwan Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure Southeast Asia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Southeast Asia Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure India Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure India Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table India Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table India Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure India Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table India Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table India Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure India Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure Australia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Australia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Australia Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Australia Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Australia Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Australia Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Australia Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Australia Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Australia Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Asia-Pacific Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Asia-Pacific Bioengineered Protein Drugs Price and Trend Forecast (2018-2023) Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure Asia-Pacific Bioengineered Protein Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure Asia-Pacific Bioengineered Protein Drugs Revenue Market Share Forecast by Regions in 2023 Figure China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Korea Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Korea Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Japan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Taiwan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Taiwan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure India Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Australia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Australia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Forecast by Type (2018-2023) Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share Forecast by Type (2018-2023) Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure Asia-Pacific Bioengineered Protein Drugs Revenue Market Share Forecast by Type (2018-2023) Table Asia-Pacific Bioengineered Protein Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table Asia-Pacific Bioengineered Protein Drugs Sales (K Units) Forecast by Application (2018-2023) Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott Laboratories F. Hoffmann-La Roche Ltd Amgen, Inc. Bayer AG Merck & Co., Inc. Dr. Reddy's Laboratories Ltd. Biocon Ltd. Eli Lilly and Company Sanofi GlaxoSmithKline plc Johnson & Johnson JanssenNovartis AG Panacea Biotec ProBioGen AG